Edifoligide (sodium)
Edifoligide sodium is a decoy oligonucleotide that binds to and inhibits E2F transcription factors and thus may prevent neointimal hyperplasia and vein graft failure
Product Specifications
Product Name Alternative
CGT 003 (sodium)
UNSPSC
12352208
Target
Early 2 Factor (E2F)
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Inflammation/Immunology
Smiles
[Edifoligide(sodium)]
References & Citations
[1]Lopes RD, Williams JB, Mehta RH, et al. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J. 2012;164 (3) :379-386.e1.|[2]Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294 (19) :2446-2454.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3471803 1.0 µg DNA
Donson sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
bs-6560R-BF488 100 µL
ORP4/OSBP2 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details 